Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors.
暂无分享,去创建一个
M. Tiemann | R. Buettner | S. Merkelbach-Bruse | J. Fassunke | S. Michels | S. Wagener-Ryczek | C. Heydt | M. Falk | L. Heukamp | C. Alidousty | J. Sueptitz | J. Wolf